Company · CIK 0001425205 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 FMForm 4 → | Sep 10, 5:01 pm EDT | Frederick G VogtInterim CEO & General Counsel, Director | 22,264 | $8.70 | $57,751 | 595,447 | — | |
| Sep 8, 2026 FMForm 4 → | Sep 10, 5:00 pm EDT | Igor BilinskyChief Operating Officer | 11,789 | $8.70 | $34,591 | 142,074 | — | |
| Sep 8, 2026 FMForm 4 → | Sep 10, 5:00 pm EDT | Raj K. PuriChief Regulatory Officer | 14,244 | $8.70 | $38,959 | 256,364 | — | |
| Sep 1, 2026 FMForm 4 → | Sep 3, 5:02 pm EDT | Frederick G VogtInterim CEO & General Counsel, Director | 59,371 | $8.28 | $146,573 | 586,459 | — | |
| Sep 1, 2026 FMForm 4 → | Sep 3, 5:02 pm EDT | Raj K. PuriChief Regulatory Officer | 7,978 | $8.28 | $20,766 | 251,076 | — | |
| Sep 1, 2026 FMForm 4 → | Sep 3, 5:00 pm EDT | Igor BilinskyChief Operating Officer | 13,261 | $8.28 | $37,028 | 138,237 | — | |
| Aug 10, 2026 FMForm 4 → | Aug 12, 5:30 pm EDT | Daniel Gordon KirbyChief Commercial Officer | 12,437 | $6.40 | $15,590 | 154,511 | — | |
| Aug 6, 2026 FMForm 4 → | Aug 10, 5:30 pm EDT | Corleen M. RocheChief Financial Officer | 71,233 | $6.21 | $131,888 | 28,757 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 10, 5:01 pm EDT | Frederick G VogtInterim CEO & General Counsel, Director | 15,626 | — | — | 93,756 | — | |
| Sep 8, 2026 MForm 4 → | Sep 10, 5:00 pm EDT | Igor BilinskyChief Operating Officer | 7,813 | — | — | 46,878 | — | |
| Sep 8, 2026 MForm 4 → | Sep 10, 5:00 pm EDT | Raj K. PuriChief Regulatory Officer | 9,766 | — | — | 58,599 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 5:02 pm EDT | Frederick G VogtInterim CEO & General Counsel, Director | 41,669 | — | — | 83,338 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 5:02 pm EDT | Raj K. PuriChief Regulatory Officer | 5,470 | — | — | 10,939 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 5:00 pm EDT | Igor BilinskyChief Operating Officer | 8,789 | — | — | 17,580 | — | |
| Aug 10, 2026 MForm 4 → | Aug 12, 5:30 pm EDT | Daniel Gordon KirbyChief Commercial Officer | 10,001 | — | — | 60,003 | — | |
| Aug 6, 2026 MForm 4 → | Aug 10, 5:30 pm EDT | Corleen M. RocheChief Financial Officer | 49,995 | — | — | 100,005 | — |